Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government
Veterans Benefits and Health Care About VA Find a VA Location

VA Health Systems Research

Go to the VA ORD website
Go to the QUERI website

CDA 09-027 – HSR Study

 
CDA 09-027
Optimizing Care of Atrial Fibrillation an Atrial Flutter
Minang Turakhia, MD MS
VA Palo Alto Health Care System, Palo Alto, CA
Palo Alto, CA
Funding Period: September 2009 - August 2014
BACKGROUND/RATIONALE:
The overarching goal of the work is to optimize care of atrial fibrillation and atrial flutter (AF, collectively) in the Veterans Health Administration (VHA), and to develop performance and quality measures for both of stroke prevention and arrhythmia management.

AF is exceedingly common in veterans. In veterans, the prevalence of AF among 29,587 outpatients receiving electrocardiograms in the VA Palo Alto Health Care System (VAPAHCS) was 8.3%. Due to rising rates of obesity and hypertension in young adults, the age-adjusted incidence of AF increasing and is therefore expected to affect more Veterans at younger ages.

OBJECTIVE(S):
Objective 1: To evaluate the quality of anticoagulation care in the VHA for stroke prevention in patients with AF

Objective 2: To evaluate the quality of arrhythmia management care in Veterans with AF

Objective 3: To pilot a screening program for AF in patients at high-risk for AF

METHODS:
For Objectives 1 and 2, I will perform two retrospective studies using linked VA and Medicare administrative data. For Objective 1, I will use an existing database to 1) characterize processes of care for stroke prevention for AF in the VHA; 2) determine the relationship of patient, provider, and facility characteristics to processes of stroke prevention care; 3) determine clinical outcomes associated with processes of stroke prevention care. For Objective 2, I will link this dataset to additional data sources to 1) characterize the use of different AF management strategies in the VHA; 2) identify facility-, provider-, and patient-level predictors of strategy selection; 3) determine clinical outcomes associated with each treatment strategy. For Objective 3, I will pilot a screening program for AF in patients at high risk of having AF. My current work on Objectives 1 and 2 has indicated that the CHADS2 score, used to estimate stroke risk in patients diagnosed with AF, has similar test discrimination in patients without known AF. Extending outpatient ambulatory screening to high-risk patients may permit detection of undiagnosed AF and therefore inform stroke prevention.

FINDINGS/RESULTS:
Not yet available.

IMPACT:
Atrial fibrillation and flutter (collectively, AF) are conditions of very high prevalence among Veterans. Identification of patient-, provider-, and facility-level factors associated with quality of AF care or outcomes across the entire VHA would be the first step to improve care system-wide. These data can help stimulate the creation of VA Office Quality and Performance, and also national and international society guidelines for AF management. Moreover, our pilot screening study has demonstrated the feasibility of screening for silent AF among high risk patients, and the high yield of atrial arrhythmias found in this study could indicate risk of developing of AF or could represent an independent stroke risk factor. Together, these projects have the potential to reduce the overall public health burden of stroke and decrease morbidity, mortality, hospitalizations, and expenditures related to management of AF.

External Links for this Project

Dimensions for VA

Dimensions for VA is a web-based tool available to VA staff that enables detailed searches of published research and research projects.

Learn more about Dimensions for VA.

VA staff not currently on the VA network can access Dimensions by registering for an account using their VA email address.     Search Dimensions for this project

PUBLICATIONS:

Journal Articles

  1. Turakhia MP, Wang PJ. "Low ejection fraction prophylaxis" with implantable defibrillators in the elderly: call for a randomized trial? Heart Rhythm. 2009 Aug 1; 6(8):1144-5. [view]
  2. Heidenreich PA, Tsai V, Curtis J, Wang Y, Turakhia MP, Masoudi FA, Varosy PD, Goldstein MK. A validated risk model for 1-year mortality after primary prevention implantable cardioverter defibrillator placement. American heart journal. 2015 Aug 1; 170(2):281-289.e2. [view]
  3. Gupta A, Hoang DD, Karliner L, Tice JA, Heidenreich P, Wang PJ, Turakhia MP. Ability of microvolt T-wave alternans to modify risk assessment of ventricular tachyarrhythmic events: a meta-analysis. American heart journal. 2012 Mar 1; 163(3):354-64. [view]
  4. Woods CE, Friday K, Wang P, Turakhia MP. Abrupt bradycardia and grouped beating during treadmill testing: a mimic of upper rate behavior. Heart Rhythm. 2012 Jul 1; 9(7):1165-7. [view]
  5. Eapen ZJ, Mi X, Qualls LG, Hammill BG, Fonarow GC, Turakhia MP, Heidenreich PA, Peterson ED, Curtis LH, Hernandez AF, Al-Khatib SM. Adherence and persistence in the use of warfarin after hospital discharge among patients with heart failure and atrial fibrillation. Journal of cardiac failure. 2014 Jan 1; 20(1):23-30. [view]
  6. Shore S, Carey EP, Turakhia MP, Jackevicius CA, Cunningham F, Pilote L, Bradley SM, Maddox TM, Grunwald GK, Barón AE, Rumsfeld JS, Varosy PD, Schneider PM, Marzec LN, Ho PM. Adherence to dabigatran therapy and longitudinal patient outcomes: insights from the veterans health administration. American heart journal. 2014 Jun 1; 167(6):810-7. [view]
  7. Shen JI, Turakhia MP, Winkelmayer WC. Anticoagulation for atrial fibrillation in patients on dialysis: are the benefits worth the risks? Current Opinion in Nephrology and Hypertension. 2012 Nov 1; 21(6):600-6. [view]
  8. Azarbal F, Welles CC, Wong JM, Whooley MA, Schiller NB, Turakhia MP. Association of CHADS2, CHA2DS2-VASc, and R2CHADS2 scores with left atrial dysfunction in patients with coronary heart disease (from the Heart and Soul study). The American journal of cardiology. 2014 Apr 1; 113(7):1166-72. [view]
  9. Johnson CJ, Scheinman MA, Turakhia MP. Bizarre and wide QRS after liver transplant--quiz case. JAMA internal medicine. 2013 Jun 10; 173(11):953-5. [view]
  10. Turakhia MP, Solomon MD, Jhaveri M, Davis P, Eber MR, Conrad R, Summers N, Lakdawalla D. Burden, timing, and relationship of cardiovascular hospitalization to mortality among Medicare beneficiaries with newly diagnosed atrial fibrillation. American heart journal. 2013 Sep 1; 166(3):573-80. [view]
  11. Turakhia M, Solomon M, Jhaveri M, Davis P, Conrad R, Summers N, Lakdawalla D. Cardiovascular Hospitalization is a Strong Predictor of Mortality in Medicare Beneficiaries with Newly Diagnosed Atrial Fibrillation. Journal of the American College of Cardiology. 2012 Mar 27; 59(13s1):E723-E723. [view]
  12. Boriani G, Savelieva I, Dan GA, Deharo JC, Ferro C, Israel CW, Lane DA, La Manna G, Morton J, Mitjans AM, Vos MA, Turakhia MP, Lip GY, Document reviewers. Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of The Working Groups On Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of The European Society of Cardiology. 2015 Aug 1; 17(8):1169-96. [view]
  13. Gupta A, Gholami P, Turakhia MP, Friday K, Heidenreich PA. Clinical reminders to providers of patients with reduced left ventricular ejection fraction increase defibrillator referral: a randomized trial. Circulation. Heart failure. 2014 Jan 1; 7(1):140-5. [view]
  14. Lakdawalla D, Turakhia MP, Jhaveri M, Mozaffari E, Davis P, Bradley L, Solomon MD. Comparative effectiveness of antiarrhythmic drugs on cardiovascular hospitalization and mortality in atrial fibrillation. Journal of comparative effectiveness research. 2013 May 1; 2(3):301-12. [view]
  15. Lenihan CR, Montez-Rath ME, Shen JI, Scandling JD, Turakhia MP, Chang TI, Winkelmayer WC. Correlates and outcomes of warfarin initiation in kidney transplant recipients newly diagnosed with atrial fibrillation. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2015 Feb 1; 30(2):321-9. [view]
  16. Freeman JV, Zhu RP, Owens DK, Garber AM, Hutton DW, Go AS, Wang PJ, Turakhia MP. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation. Annals of internal medicine. 2011 Jan 4; 154(1):1-11. [view]
  17. Freeman JV, Ullal A, Turakhia M. Cost-Effectiveness of Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy. Advances in ICD Therapy. Cardiac Electrophysiology Review. 2011 Sep 1; 3(3):421-440. [view]
  18. Solomon MD, Ullal AJ, Hoang DD, Freeman JV, Heidenreich P, Turakhia MP. Cost-effectiveness of pharmacologic and invasive therapies for stroke prophylaxis in atrial fibrillation. Journal of cardiovascular medicine. 2012 Feb 1; 13(2):86-96. [view]
  19. Al-Khatib SM, Calkins H, Eloff BC, Kowey P, Hammill SC, Ellenbogen KA, Marinac-Dabic D, Waldo AL, Brindis RG, Wilbur DJ, Jackman WM, Yaross MS, Russo AM, Prystowsky E, Varosy PD, Gross T, Pinnow E, Turakhia MP, Krucoff MW. Developing the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a collaborative pan-stakeholder critical path registry model: a Cardiac Safety Research Consortium "Incubator" Think Tank. American heart journal. 2010 Oct 1; 160(4):619-26. [view]
  20. Turakhia MP, Hoang DD, Zimetbaum P, Miller JD, Froelicher VF, Kumar UN, Xu X, Yang F, Heidenreich PA. Diagnostic utility of a novel leadless arrhythmia monitoring device. The American journal of cardiology. 2013 Aug 15; 112(4):520-4. [view]
  21. Turakhia MP, Hoang DD, Xu X, Frayne S, Schmitt S, Yang F, Phibbs CS, Than CT, Wang PJ, Heidenreich PA. Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: The Retrospective Evaluation and Assessment of Therapies in AF (TREAT-AF) study. American heart journal. 2013 Jan 1; 165(1):93-101.e1. [view]
  22. Keach JW, Bradley SM, Turakhia MP, Maddox TM. Early detection of occult atrial fibrillation and stroke prevention. Heart (British Cardiac Society). 2015 Jul 1; 101(14):1097-102. [view]
  23. Uberoi A, Jain NA, Perez M, Weinkopff A, Ashley E, Hadley D, Turakhia MP, Froelicher V. Early repolarization in an ambulatory clinical population. Circulation. 2011 Nov 15; 124(20):2208-14. [view]
  24. Turakhia MP, Shafrin J, Bognar K, Goldman DP, Mendys PM, Abdulsattar Y, Wiederkehr D, Trocio J. Economic Burden of Undiagnosed Nonvalvular Atrial Fibrillation in the United States. The American journal of cardiology. 2015 Sep 1; 116(5):733-9. [view]
  25. Prasad M, Flowers E, Mathur A, Sridhar V, Molina C, Turakhia M. Effectiveness of a community screening program for metabolic syndrome and cardiovascular risk factor identification in young South Asians adults. Diabetes & metabolic syndrome. 2015 Jan 1; 9(1):38-41. [view]
  26. Turakhia MP, Ullal AJ, Hoang DD, Than CT, Miller JD, Friday KJ, Perez MV, Freeman JV, Wang PJ, Heidenreich PA. Feasibility of extended ambulatory electrocardiogram monitoring to identify silent atrial fibrillation in high-risk patients: the Screening Study for Undiagnosed Atrial Fibrillation (STUDY-AF). Clinical Cardiology. 2015 May 1; 38(5):285-92. [view]
  27. Hlatky MA, Reynolds M, Turakhia M. Foreword: health policy and cardiac electrophysiology. Journal of Interventional Cardiac Electrophysiology. 2013 Mar 13; 36(2):97. [view]
  28. Lewis WR, Piccini JP, Turakhia MP, Curtis AB, Fang M, Suter RE, Page RL, Fonarow GC. Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation. Circulation. Cardiovascular quality and outcomes. 2014 Sep 1; 7(5):770-7. [view]
  29. Perez MV, Al-Ahmad AA, Wang PJ, Turakhia MP. Inappropriate pacing in a patient with managed ventricular pacing: what is the cause? Heart Rhythm. 2010 Sep 1; 7(9):1336-7. [view]
  30. Cheng Z, Turakhia M, Lo R, Gupta A, Zei PC, Hsia HH, Al-Ahmad A, Wang PJ. Incidence and clinical predictors of low defibrillation safety margin at time of implantable defibrillator implantation. Journal of Interventional Cardiac Electrophysiology. 2012 Jun 1; 34(1):93-100. [view]
  31. Turakhia MP, McManus DD, Whooley MA, Schiller NB. Increase in end-systolic volume after exercise independently predicts mortality in patients with coronary heart disease: data from the Heart and Soul Study. European heart journal. 2009 Oct 1; 30(20):2478-84. [view]
  32. Turakhia MP, Santangeli P, Winkelmayer WC, Xu X, Ullal AJ, Than CT, Schmitt S, Holmes TH, Frayne SM, Phibbs CS, Yang F, Hoang DD, Ho PM, Heidenreich PA. Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study. Journal of the American College of Cardiology. 2014 Aug 19; 64(7):660-8. [view]
  33. Shih MC, Turakhia M, Lai TL. Innovative designs of point-of-care comparative effectiveness trials. Contemporary clinical trials. 2015 Nov 1; 45(Pt A):61-8. [view]
  34. Turakhia M, Yang F, Xu X, Winkelmayer W, Hoang DD, Heidenreich PA. Interaction among digoxin use, kidney function, and mortality in patients with atrial fibrillation: the TREAT-AF study. Journal of the American College of Cardiology. 2012 Mar 27; 59(13s1):E685-E685. [view]
  35. Turakhia MP. JICE goes "social". Journal of Interventional Cardiac Electrophysiology. 2011 Nov 1; 32(2):79-80. [view]
  36. Turakhia MP, Estes NA, Drew BJ, Granger CB, Wang PJ, Knight BP, Page RL, Electrocardiography and Arrhythmias Committee of the American Heart Association Council on Clinical Cardiology and Council on Cardiovascular Nursing. Latency of ECG displays of hospital telemetry systems: a science advisory from the American Heart Association. Circulation. 2012 Sep 25; 126(13):1665-9. [view]
  37. Welles CC, Ku IA, Kwan DM, Whooley MA, Schiller NB, Turakhia MP. Left atrial function predicts heart failure hospitalization in subjects with preserved ejection fraction and coronary heart disease: longitudinal data from the Heart and Soul Study. Journal of the American College of Cardiology. 2012 Feb 14; 59(7):673-80. [view]
  38. Furie KL, Goldstein LB, Albers GW, Khatri P, Neyens R, Turakhia MP, Turan TN, Wood KA, American Heart Association Stroke Council, Council on Quality of Care and Outcomes Research, Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Peripheral Vascular Disease. Oral antithrombotic agents for the prevention of stroke in nonvalvular atrial fibrillation: a science advisory for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012 Dec 1; 43(12):3442-53. [view]
  39. Ristow B, Ali S, Na B, Turakhia MP, Whooley MA, Schiller NB. Predicting heart failure hospitalization and mortality by quantitative echocardiography: is body surface area the indexing method of choice? The Heart and Soul Study. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. 2010 Apr 1; 23(4):406-13. [view]
  40. Flowers E, Molina C, Mathur A, Prasad M, Abrams L, Sathe A, Malhotra D, Basra R, Malgesini N, Ratnam G, Aouizerat BE, Turakhia MP. Prevalence of metabolic syndrome in South Asians residing in the United States. Metabolic Syndrome and Related Disorders. 2010 Oct 1; 8(5):417-23. [view]
  41. Turakhia MP. Quality of stroke prevention care in atrial fibrillation: many moving targets. Circulation. Cardiovascular quality and outcomes. 2011 Jan 1; 4(1):5-8. [view]
  42. Wong JM, Welles CC, Azarbal F, Whooley MA, Schiller NB, Turakhia MP. Relation of left atrial dysfunction to ischemic stroke in patients with coronary heart disease (from the heart and soul study). The American journal of cardiology. 2014 May 15; 113(10):1679-84. [view]
  43. Turakhia MP. Sudden cardiac death and implantable cardioverter-defibrillators. American Family Physician. 2010 Dec 1; 82(11):1357-66. [view]
  44. Welles CC, Whooley MA, Na B, Ganz P, Schiller NB, Turakhia MP. The CHADS(2) score predicts ischemic stroke in the absence of atrial fibrillation among subjects with coronary heart disease: Data from the Heart and Soul Study. American heart journal. 2011 Sep 1; 162(3):555-61. [view]
  45. Perez MV, Uberoi A, Jain NA, Ashley E, Turakhia MP, Froelicher V. The prognostic value of early repolarization with ST-segment elevation in African Americans. Heart Rhythm. 2012 Apr 1; 9(4):558-65. [view]
  46. Goldstein BA, Arce CM, Hlatky MA, Turakhia M, Setoguchi S, Winkelmayer WC. Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States. Circulation. 2012 Nov 6; 126(19):2293-301. [view]
  47. Turakhia MP, Ullal AJ. US health care policy and reform: implications for cardiac electrophysiology. Journal of Interventional Cardiac Electrophysiology. 2013 Mar 1; 36(2):129-36. [view]
  48. Nazarian S, Reynolds MR, Ryan MP, Wolff SD, Mollenkopf SA, Turakhia MP. Utilization and likelihood of radiologic diagnostic imaging in patients with implantable cardiac defibrillators. Journal of Magnetic Resonance Imaging : Jmri. 2016 Jan 1; 43(1):115-27. [view]
  49. Turakhia MP, Scheinman M, Badhwar N. Wolff-Parkinson-White syndrome: where is the pathway? Indian pacing and electrophysiology journal. 2009 Mar 15; 9(2):130-3. [view]
Journal Other

  1. Jackevicius C, Avgil M, Tu J, Essebag V, Eisenberg M, Atzema C, Ho M, Turakhia M, Lu L, Behlouli H, Pilote L. Adherence With Dabigatran Therapy in Patients With Atrial Fibrillation. [Abstract]. Circulation. 2013 Nov 26; 2013(128):A15620. [view]
  2. Shore S, Ho PM, Lambert-Kerzner A, Cunningham F, McCarren M, Longo L, Barón A, Plomondon M, Maddox TM, Rose AJ, Turakhia M. Anticoagulation clinic provider’s perspective on management of patients on target specific oral anticoagulants: insights from the Veterans Affairs Health Care System. [Abstract]. Circulation. Cardiovascular quality and outcomes. 2014 Sep 1; 2014(7):A137. [view]
  3. Perino AC, Hoang DD, Holmes TH, Santangeli P, Turakhia M. Citation Bias Favoring Studies With Higher Success Rates for Catheter Ablation of Atrial Fibrillation. [Abstract]. Circulation. 2013 Nov 26; 2013(128):A11938. [view]
  4. Schneider PM, Liu W, Grunwald GK, Chan PS, Nallamothu BK, Sasson C, Varosy P, Turakhia M, Ogunnaike B, Ho PM, Bradley SM. Comparative Efficacy of Biphasic Waveform Defibrillation Energies for In-Hospital Cardiac Arrest: Insights from the Get With The Guidelines--Resuscitation Registry. [Abstract]. Circulation. 2014 Jul 25; 2014(130):A237. [view]
  5. Freeman JV, Turakhia M. Dabigatran Compared With Warfarin for Stroke Prevention in Atrial Fibrillation [letter reply]. Annals of internal medicine. 2011 Apr 19; 154(8):570-571. [view]
  6. Tung CE, Turakhia M, Lansberg M. Diagnostic Yield of an Extended Ambulatory Cardiac Rhythm Monitor in Patients With TIA or Stroke. [Abstract]. Stroke. 2014 Feb 28; 2014(45):AWMP63. [view]
  7. Prasad M, Flowers E, Mathur A, Molina m, Turakhia M. Effectiveness Of A Community Screening Program For Metabolic Syndrome And Cardiovascular Risk Factor Identification In Young South Asians Adults. [Abstract]. Circulation. 2014 Mar 25; 2014(129):AP175. [view]
  8. Shore S, Carey E, Turakhia M, Jackevicius CA, Cunningham F, Pilote L, Baron A, Grunwald G, Bradley SM, Maddox TM, Rumsfeld JS, Varosy PD, Ho M. Patterns of Adherence to Dabigatran and its Association with Outcomes. [Abstract]. Circulation. 2013 Nov 26; 128(22 Suppl):A16864. [view]
  9. Schneider PM, Liu W, Grunwald GK, Chan PS, Nallamothu BK, Sasson C, Varosy PD, Turakhia M, Ho PM, Bradley SM. Patterns of Waveform and Energy Use in Defibrillation for Cardiac Arrest: Insights from the Get With The Guidelines-Resuscitation Registry. [Abstract]. Circulation. Cardiovascular quality and outcomes. 2014 Jun 4; 2014(7):A181. [view]
  10. Johnson CJ, Turakhia MP. Phenytoin toxicity unlikely to result in arrhythmias--reply. JAMA internal medicine. 2014 Jan 1; 174(1):167-8. [view]
  11. Turakhia M, Shafrin J, Bognar K, Brown JB, Trocio J, Wiederkehr D, Goldman DP. Prevalence of undiagnosed non-valvular atrial fibrillation in the United States. [Abstract]. Circulation. Cardiovascular quality and outcomes. 2014 Sep 1; 2014(7):A274. [view]
  12. Rajaei S, Groeneveld P, Teerlink J, Whooley M, Turakhia M, Richman IB, Sahay A, Kini V, Heidenreich PA. Racial Disparities in echocardiography use within the Veterans Administration and Medicare systems. [Abstract]. Circulation. Cardiovascular quality and outcomes. 2015 May 1; 2015(8):A217. [view]
  13. Yong C, Xu X, Than CT, Ullal A, Schmitt S, Azarbal F, Heidenreich PA, Turakhia M. Racial Disparities in Warfarin Time in INR Therapeutic Range in Patients With Atrial Fibrillation: Findings From the TREAT-AF Study. [Abstract]. Circulation. 2013 Nov 26; 2013(128):A14134. [view]
  14. Turakhia MP, Holmes T. Regarding "feasibility and safety of same-day discharge after implantable cardioverter defibrillator placement for primary prevention". Pacing and Clinical Electrophysiology. 2014 Jan 1; 37(1):131. [view]
  15. Rajaei S, Groeneveld P, Teerlink J, Whooley M, Turakhia M, Richman IB, Sahay A, Kini V, Heidenreich PA. Use of Echocardiography and Nuclear Scintigraphy for Patients with Heart Failure in the Veterans Administration and Medicare Systems. [Abstract]. Circulation. Cardiovascular quality and outcomes. 2015 May 1; 2015(8):A315. [view]
  16. Turakhia MP, Heidenreich PA. Using restriction to minimize bias in observational studies. JAMA : the journal of the American Medical Association. 2010 Dec 1; 304(21):2359; author reply 2359-60. [view]
  17. Winkelmayer WC, Turakhia MP. Warfarin treatment in patients with atrial fibrillation and advanced chronic kidney disease: sins of omission or commission? JAMA : the journal of the American Medical Association. 2014 Mar 5; 311(9):913-5. [view]
Book Chapters

  1. Yang F, Turakhia M, Froelicher V. Exercise-Induced Arrhythmias. In: Zipes DP, Jalife J, editors. Cardiac Electrophysiology: From Cell to Bedside. 6 ed. Philadelphia, PA: Elsevier Saunders; 2013. Chapter 63. 613-620 p. [view]
  2. Wang PJ, Al-Ahmad A, Hsia HH, Zei PC, Turakhia M, Perez M, Eversull CS. Intraprocedural Techniques: Angioscopy and Optical Imaging. In: Cardiac Imaging in Electrophysiology. New York, NY: Springer; 2012. Chapter 10. 149-159 p. [view]
  3. Reynolds MR, Turakhia M, Pinto DS, Josephson ME. Sudden Cardiac Death. In: Hurst's the Heart Manual of Cardiology. 12 ed. USA: McGraw-Hill Companies, Inc.; 2009. Chapter 17. 207-216 p. [view]
  4. Wang PJ, Al-Ahmad A, Hsia HH, Zei PC, Turakhia M, Perez MV. Timing Cycles of Implantable Devices. In: Clinical Cardiac Pacing, Defibrillation, and Resynchronization Therapy. 4 ed. Philadelphia, PA: Saunders (Elsevier); 2011. Chapter 28. 813-843 p. [view]
Center Products

  1. Turakhia M. Challenging device tracings. Bay Area Peninsula Electrophysiology Society Meeting; Palo Alto, CA. 2012 Feb 28. [view]
  2. Turakhia M. Defining the unmet needs for stroke prevention in AF: are the new drugs enough? Presented for the Stanford Biodesign New Arrhythmia Technologies Retreat, in conjunction with the Heart Rhythm Society Scientific Sessions. Boston, MA. 2012 May 8. [view]
  3. Turakhia M. Implementation and comparative effectiveness of new oral anticoagulants. Presented to the VA National Cardiac Device Surveillance Program (VANCDSP), in conjunction with the Heart Rhythm Society Scientific Sessions. Boston, MA. 2012 May 7. [view]
  4. Turakhia M. Linking large datasets (VA and Medicare) to understand dual health care system use, quality of care, and outcomes in patients with atrial fibrillation. 2011 Dec 1. [view]
  5. Turakhia M. Outcomes Research and Health Policy in Electrophysiology: Implications for Device Development. Presented for St. Jude Medical Research Lyceum Session. Sylmar, CA. 2012 Apr 19. [view]
VA Cyberseminars

  1. Turakhia M. Atrial Fibrillation: Why We Have To Do Better (But We Need a Little Help). [Cyberseminar]. 2013 Dec 4. [view]
  2. Turakhia M. Choosing the Right Anticoagulant in Atrial Fibrillation - A Get With The Guidelines-AFIB and Get With The Guidelines-Stroke Webinar, American Heart Association. [Cyberseminar]. 2014 Jan 8. [view]
  3. Turakhia M, Wilkoff B, Deering T. Healthcare Utilization and Expenditures associated with ICD Shocks. ICD Shock Reduction: Update on Economic Impact and Therapeutic Options. [Cyberseminar]. 2013 Nov 7. [view]
  4. Turakhia M. The Business Case to Improve Quality of Care in Atrial Fibrillation: What Your Hospital Needs to Know. American Heart Association Webinar. [Cyberseminar]. 2014 Mar 12. [view]
Conference Presentations

  1. Lo R, Perez M, Gupta A, Tam F, Natale A, Turakhia M. A novel method of pressure measurements in cardiac chambers utilizing irrigated tip ablation catheters. Paper presented at: Heart Rhythm Society Annual Scientific Sessions; 2009 May 15; Boston, MA. [view]
  2. Turakhia M. A Patient With Ventricular Arrhythmias Who May Not Benefit From an ICD. Case-Based Learning: Challenging Cases in Device Management. Presented at: American College of Cardiology Annual Scientific Session; 2014 Mar 29; Washington, DC. [view]
  3. Chisholm M, Turakhia M. A Primer on Social Media as a Tool in CV Medicine and Research: Using Twitter to Communicate Your Research. From Insight to Impact: Better Communication Strategies to Unlock the Power of your Research. Workshop. Presented at: American Heart Association Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke Annual Scientific Sessions; 2014 Jun 2; Baltimore, MD. [view]
  4. Gupta A, Hoang DH, Karliner L, Tice J, Turakhia M. Ability of Microvolt T-Wave Alternans to Modify Pre-Test Risk of Ventricular Tachyarrhythmic Events: A Meta-Analysis. Paper presented at: Heart Rhythm Society Annual Scientific Sessions; 2010 May 14; Denver, CO. [view]
  5. Turakhia M. Across the Arrhythmia Spectrum: from ED to Discharge – Case Study Presentations. Presented at: Stanford University Cardiac Arrhythmia, Sudden Death, Inherited Disease, Athletes Conference; 2012 Jun 22; Monterey, CA. [view]
  6. Jackevicius C, Avgil M, Tu J, Essebag V, Eisenberg M, Atzema C, Ho M, Turakhia M, Behlouli H, Pilote L. Adherence with Dabigatran Therapy in Patients with Atrial Fibrillation. Paper presented at: American Heart Association Scientific Sessions and Resuscitation Annual Science Symposium; 2013 Nov 19; Dallas, TX. [view]
  7. Turakhia M, Yang F, Xu X, Winkelmayer W, Hoang DD, Heidenreich PA. Amiodarone use is not associated with mortality in patients with atrial fibrillation and kidney dysfunction or dialysis: the TREAT-AF study. Poster session presented at: American College of Cardiology Annual Scientific Session; 2012 Mar 27; Chicago IL. [view]
  8. Shore S, Ho PM, Lambert-Kerzner A, Cunningham F, McCarren M, Longo L, Barón A, Plomondon M, Maddox TM, Rose AJ, Turakhia M. Anticoagulation clinic provider’s perspective on management of patients on target specific oral anticoagulants: insights from the Veterans Affairs Health Care System. Poster session presented at: American Heart Association Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke Annual Scientific Sessions; 2014 Jun 2; Bethesda, MD. [view]
  9. Frayne SM, Turakhia M, Moos RH, Friedman SA, Schmitt SK, Berlowitz D, Phibbs CS. Anticoagulation outcomes in atrial fibrillation: Impact of mental illness. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2011 May 6; Phoenix, AZ. [view]
  10. Frayne SM, Turakhia M, Moos RH, Friedman SA, Schmitt SK, Berlowitz D, Phibbs CS. Anticoagulation outcomes in atrial fibrillation: Impact of mental illness. Paper presented at: AcademyHealth Annual Research Meeting; 2011 Jun 13; Seattle, WA. [view]
  11. Turakhia M. Appropriate Use of Implantable Cardioverter-Defibrillators. Presented at: American College of Cardiology Advances in Heart Disease Annual Meeting; 2011 Dec 16; San Francisco, CA. [view]
  12. Phibbs CS, Friedman SA, Turakhia M, Chiu VY, Moos RH, Schmitt SK, Le SY, Frayne SM. Are Atrial Fibrillation Patients With Mental Health Conditions Treated Differently? Poster session presented at: Society of General Internal Medicine Annual Meeting; 2010 Apr 30; Minneapolis, MN. [view]
  13. Turakhia M, Solomon M, Jhaveri M, Davis P, Conrad R, Summers N, Lakdawalla D. Association of cardiovascular hospitalization to mortality in newly-diagnosed Atrial Fibrillation. Poster session presented at: American College of Cardiology Annual Scientific Session; 2012 Mar 26; Chicago, IL. [view]
  14. Turakhia M, Ziegler PD, Schmitt SS, Chang Y, Fan J, Bucksa A, Than CT, Singer DE. Atrial Arrhythmia Burden Increases Just Proximal to Stroke: Insights from Remote Monitoring in a National Health Care System. Paper presented at: Heart Rhythm Society Annual Scientific Sessions; 2014 May 8; San Francisco, CA. [view]
  15. Turakhia M. Atrial Fibrillation and Other Supraventricular Arrhythmias: Guideline Update. Core Curriculum: Cardiac Electrophysiology. Presented at: American College of Cardiology Annual Scientific Session; 2014 Mar 29; Washington, DC. [view]
  16. Frayne SM, Turakhia M, Schmitt SK, Friedman SA, Chiu VY, Moos RH, Heidenreich PA, Berlowitz D, Phibbs CS. Atrial Fibrillation Management in Patients with Mental Illness: Are they Anticoagulated? Are They Monitored? Poster session presented at: VA HSR&D National Meeting; 2011 Feb 25; National Harbor, MD. [view]
  17. Joseph SA, Yang Y, Ng RK, Narayan SM, Varosy P, Kumar UN, Rao R, Turakhia M, Keung EC, Badhwar N, Lee BK, Tseng ZH, Olgin JE, Scheinman M. Atypical ECG Characteristics of Atrial Flutter as an Exclusion to Ablation: A Missed Opportunity. Paper presented at: Cardiac Society of Australia and New Zealand Annual Scientific Meeting; 2009 Aug 14; Sydney, Australia. [view]
  18. Turakhia M. Autonomics, Arrhythmias, and HF: Managing the Intersection of Complex Cardiovascular Disease - Chair, Joint Session. Presented at: Heart Rhythm Society Annual Scientific Sessions; 2014 May 7; San Francisco, CA. [view]
  19. Xu X, Yang F, Hoang DD, Than CT, Heidenreich PA, Turakhia M. Bleeding Risk Differentially Affects Warfarin Prescription Rates Among Primary Care Versus Cardiology Specialty Management of Newly Diagnosed Atrial Fibrillation. The TREAT-AF Study. Presented at: Heart Rhythm Society Annual Scientific Sessions; 2012 May 9; Boston, MA. [view]
  20. Kalra A, Pokharel Y, Hira RS, Risch S, Vicera V, Li Q, Kalra R, Kerkar PG, Kumar G, Maddox TM, Oetgen WJ, Glusenkamp N, Turakhia MP, Virani SS. Cardiovascular Disease Performance Measures in the Outpatient Setting in India: Insights from the American College of Cardiology's PINNACLE India Quality Improvement Program (PIQIP). Poster session presented at: American Association of Cardiologists of Indian Origin Annual Scientific Session; 2015 Mar 15; San Diego, CA. [view]
  21. Welles CC, Na B, Whooley M, Turakhia M. CHADS2 Score Predicts Ischemic Stroke in the Absence of Atrial Fibrillation Among Patients With Coronary Heart Disease: Data from the Heart and Soul Study. Poster session presented at: American College of Cardiology Annual Scientific Session; 2011 Apr 5; New Orleans, LA. [view]
  22. Turakhia M. Challenging supraventricular tachycardia cases. Presented at: Stanford University Cardiac Arrhythmia, Sudden Death, Inherited Disease, Athletes Conference; 2012 Jun 22; Monterey, CA. [view]
  23. Perino A, Hoang DD, Holmes T, Santangeli P, Turakhia M. Citation Bias Favoring Studies with Higher Success Rates for Catheter Ablation of Atrial Fibrillation. Poster session presented at: American Heart Association Annual Scientific Sessions; 2014 Nov 18; Dallas, TX. [view]
  24. Turakhia M, Hoang DD, Zimetbaum P, Yang F, Heidenreich PA, Froelicher V. Clinical Experience and Diagnostic Yield from a National Registry of 14-day Ambulatory ECG Patch Monitoring. Poster session presented at: American College of Cardiology Annual Scientific Session; 2012 Mar 26; Chicago, IL. [view]
  25. Gupta A, Gholami P, Turakhia M, Friday K, Heidenreich PA. Clinical Reminders to Providers of Patients with Depressed Left Ventricular Ejection Fraction Increase Defibrillator Implantation: A Randomized Trial. Paper presented at: American Heart Association Annual Scientific Sessions; 2011 Nov 15; Orlando, FL. [view]
  26. Miller JD, Hoang DD, Perino A, Azarbal F, Ullal A, Than CT, Heidenreich PA, Friday KJ, Turakhia M. Comparative Effectiveness of 14-day Zio Patch-Based versus 24-hour Holter Ambulatory ECG Monitoring for Atrial Fibrillation: Insights from an Interrupted Time Series Analysis. Poster session presented at: Heart Rhythm Society Annual Scientific Sessions; 2014 May 8; San Francisco, CA. [view]
  27. Solomon M, Lakdawalla D, Turakhia M, Jhaveri M, David P, Bradley L. Comparative Effectiveness Of Antiarrhythmic Drug Therapy In Atrial Fibrillation: Focus On Cardiovascular Hospitalization And Mortality Outcomes. Poster session presented at: Society for Medical Decision Making Annual Meeting; 2011 Oct 25; Chicago, IL. [view]
  28. Turakhia M. Comparative Effectiveness of New Stroke Prevention Therapies for Atrial Fibrillation. Presented at: Heart Rhythm Society Annual Scientific Sessions; 2012 May 7; Boston, MA. [view]
  29. Schneider PM, Liu W, Grunwald GK, Chan PS, Nallamothu BK, Sasson C, Varosy P, Turakhia M, Ogunnaike B, Ho PM, Bradley SM. Comparative Efficacy of Biphasic Waveform Defibrillation Energies for In-Hospital Cardiac Arrest: Insights from the Get With The Guidelines--Resuscitation Registry. Poster session presented at: American Heart Association Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke Annual Scientific Sessions; 2014 Jun 3; Baltimore, MD. [view]
  30. Turakhia M. Coronary Disease in South Asians: Why is it so prevalent and what can we do? Presented at: University of California San Francisco School of Medicine Asian Health Symposium; 2012 Feb 10; San Francisco, CA. [view]
  31. Turakhia M. Cost-Effectiveness of Catheter Ablation for Atrial Fibrillation. Paper presented at: CARDIOSTIM World Congress in Cardiac Electrophysiology and Cardiac Techniques; 2014 Jun 18; Nice, France. [view]
  32. Freeman JV, Zhu RP, Bobulsky SC, Owens DK, Garber AM, Go AS, Wang PJ, Turakhia M. Cost-effectiveness of Dabigatran for Stroke Prevention in Nonvalvular Atrial Fibrillation. Paper presented at: Heart Rhythm Society Annual Scientific Sessions; 2010 May 14; Denver, CO. [view]
  33. Turakhia M, Zhu RP, Bobulsky SC, Owens DK, Garber AM, Freeman JV. Cost-effectiveness of Percutaneous Left Atrial Appendage Occlusion for Stroke Prevention in Nonvalvular Atrial Fibrillation. Poster session presented at: Heart Rhythm Society Annual Scientific Sessions; 2010 May 13; Denver, CO. [view]
  34. Turakhia M, Zhu RP, Bobulsky SC, Owens DK, Garber AM, Al-Ahmad A, Wang PJ, Freeman JV. Cost-effectiveness of Percutaneous Left Atrial Appendage Occlusion Versus Warfarin for Atrial Fibrillation. Poster session presented at: CARDIOSTIM World Congress in Cardiac Electrophysiology and Cardiac Techniques; 2010 Jun 14; Nice, France. [view]
  35. Turakhia M. Cost-effectiveness of stroke prevention therapies for atrial fibrillation. Paper presented at: American Heart Association Annual Scientific Sessions; 2011 Nov 14; Orlando, FL. [view]
  36. Turakhia M, Gupta A, Hoang DH, Tice J, Karliner L. Diagnostic Test Performance of Microvolt T-Wave Alternans: A Meta-Analysis. Paper presented at: CARDIOSTIM World Congress in Cardiac Electrophysiology and Cardiac Techniques; 2010 Jun 14; Nice, France. [view]
  37. Tung CE, Turakhia M, Lansberg M. Diagnostic Yield of an Extended Ambulatory Cardiac Rhythm Monitor in Patients With TIA or Stroke. Poster session presented at: American Heart Association / American Stroke Association International Stroke Conference; 2014 Feb 13; San Diego, CA. [view]
  38. Turakhia M, Xu X, Hoang DD, Heidenreich PA. Differences and trends in stroke prevention guideline adherence in primary care versus cardiology specialty management of new atrial fibrillation: The TREAT-AF study. Poster session presented at: Heart Rhythm Society Annual Scientific Sessions; 2011 May 7; San Francisco, CA. [view]
  39. Turakhia M, Xu X, Hoang DD, Heidenreich PA. Differences in medical therapy in primary care versus cardiology specialty management of new atrial fibrillation: The TREAT-AF study. Poster session presented at: Heart Rhythm Society Annual Scientific Sessions; 2011 May 7; San Francisco, CA. [view]
  40. Perez MV, Oberoi A, Jain NA, Weinkopff A, Ashley E, Turakhia M, Froelicher V. Differences in Prevalence and Prognosis of Early Repolarization Between African Americans and other Ethnic Groups. Poster session presented at: Heart Rhythm Society Annual Scientific Sessions; 2011 May 7; San Francisco, CA. [view]
  41. Eversull CS, Lin B, Quigley ML, Mourlas NJ, Al-Ahmad A, Hsia HH, Zei PC, Turakhia M, Wang PJ. Direct Intracardiac Visualization of Radiofrequency Catheter Ablation Lesions. Paper presented at: Heart Rhythm Society California Heart Rhythm Symposium; 2009 May 15; Boston, MA. [view]
  42. Hoang DD, Ullal A, Perez MV, Froelicher VF, Heidenreich PA, Yang F, Turakhia M. Early Repolarization Pattern on ECG and Risk of Arrhythmic Death: A Systematic Review. Poster session presented at: Bay Area Clinical Research Annual Symposium; 2011 Nov 4; San Francisco, CA. [view]
  43. Prasad M, Flowers E, Mathur A, Sridhar V, Molina C, Turakhia M. Effectiveness of a Community Screening Program for Metabolic Syndrome and Cardiovascular Risk Factor Identification in Young South Asians Adults. Poster session presented at: American Heart Association Epidemiology and Prevention, Nutrition, Physical Activity, and Metabolism Scientific Sessions; 2014 Mar 18; San Francisco, CA. [view]
  44. Prasad M, Flowers E, Mathur A, Molina C, Turakhia M. Effectiveness of a Screening Program to Identify Metabolic Syndrome in Young South Asians: A Community Based Study. Prevention: Gender, Race/Ethnicity, and Preventive Interventions. Poster session presented at: American College of Cardiology Annual Scientific Session; 2014 Mar 30; Washington, DC. [view]
  45. Turakhia M. Electrophysiologic maneuvers for supraventricular tachycardia. Presented at: Stanford University School of Medicine Electrophysiology Conference; 2011 Oct 13; Stanford, CA. [view]
  46. Turakhia M, Phibbs CS, Moos RH, Friedman SA, Heidenreich PA, Frayne SM. Facility volume is not associated with increased quality of anticoagulation care for patients with atrial fibrillation. Poster session presented at: American Heart Association Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke Annual Scientific Sessions; 2010 May 21; Washington, DC. [view]
  47. Turakhia M, Ullal A, Than CT, Miller J, Hoang DD, Perino A, Azarbal F, Heidenreich PA, Friday KJ. Feasibility of Outpatient Ambulatory ECG Monitoring to Screen for Silent Atrial Fibrillation: Findings from the Screening Trial for Undiagnosed Atrial Fibrillation (STUDY-AF). Poster session presented at: Heart Rhythm Society Annual Scientific Sessions; 2014 May 8; San Francisco, CA. [view]
  48. Pokharel Y, Hira RS, Shore S, Kerkar PG, Kumar G, Risch S, Vicera V, Oetgen WJ, Turakhia M, Glusenkamp N, Virani SS. Guideline Recommended Medication Use among Systolic Heart Failure Patients in India: Insights from the American College of Cardiology Practice Innovation and Clinical Excellence (PINNACLE)® India Registry. Paper presented at: Cardiological Society of India Annual Conference; 2014 Dec 5; Hyderabad, India. [view]
  49. Turakhia M, Turakhia M. Health Care Policy and Reform: Implications for Arrhythmia Care. Presented at: Advanced Concepts in Electrophysiology Meeting; 2012 Mar 31; Washington, DC. [view]
  50. Ullal AL, Than CT, Perez MV, Heidenreich PA, Turakhia M. How Consistent are the ECG Diagnostic Criteria for Early Repolarization Pattern Across Studies? (A Systematic Review and Meta-Analysis). Poster session presented at: Heart Rhythm Society Annual Scientific Sessions; 2014 May 9; San Francisco, CA. [view]
  51. Turakhia M, Than CT, Xu X, Schmitt SK, Yang F, Frayne SM, Phibbs CS, Holmes TH, Heidenreich PA. Impact of Baseline Stroke Risk and Bleeding Risk on INR Control among Patients with AF on Warfarin: Data from the TREAT-AF Study. Presented at: American Heart Association Annual Scientific Sessions; 2012 Nov 5; Los Angeles, CA. [view]
  52. Than CT, Xu X, Schmitt SK, Frayne SM, Phibbs CS, Holmes TH, Heidenreich PA, Moos RH, Berlowitz d, Go AS, Turakhia M. Impact of Dual Health Care System Use on Quality of Warfarin Anticoagulation in Atrial Fibrillation. Poster session presented at: American Heart Association Annual Scientific Sessions; 2013 May 16; Baltimore, MD. [view]
  53. Phibbs CS, Le S, Schmidt S, Turakhia M, Frayne SM. Impact of Dual Use of VA and Medicare in Outcomes in Patients with Atrial Fibrillation. Paper presented at: AcademyHealth Annual Research Meeting; 2009 Jun 28; Chicago, IL. [view]
  54. Katz DF, Turakhia M, Varosy PD, Tzou WS, Sauer WH, Aleong RG, Nguyen DT, Kao DP. In-Hospital Complications Associated With Catheter Ablation of Ventricular Tachycardia: An Analysis of 9,699 Procedures. Poster session presented at: Heart Rhythm Society Annual Scientific Sessions; 2014 May 9; San Francisco, CA. [view]
  55. Turakhia M, Yang F, Xu X, Winkelmayer W, Hoang DD, Heidenreich PA. Interaction among digoxin use, kidney function, and mortality in patients with atrial fibrillation: the TREAT-AF study. Poster session presented at: American College of Cardiology Annual Scientific Session; 2012 Mar 26; Chicago, IL. [view]
  56. Divakaruni M, Prasad M, Flowers E, Molina C, Mathur A, Sathe A, Malhortra D, Basra R, Malgesini N, Aouizerat BE, Turakhia M. Inverse association of Lp(a) concentration with metabolic syndrome components in South Asians. Paper presented at: American College of Cardiology Annual Scientific Session; 2010 Mar 14; Atlanta, GA. [view]
  57. Welles CC, Ku I, Whooley M, Schiller NB, Turakhia M. Left Atrial Function Predicts Heart Failure Hospitalization in Patients with Stable Coronary Artery Disease and Normal Ejection Fraction: Data from the Heart and Soul Study. Poster session presented at: American Heart Association Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke Annual Scientific Sessions; 2011 May 13; Washington, DC. [view]
  58. Flowers E, Molina C, Mathur A, Aouizerat B, Turakhia M. Lipoprotein Levels and Composition in South Asians Compared to the US Population. Poster session presented at: American Heart Association Epidemiology and Prevention, Nutrition, Physical Activity, and Metabolism Scientific Sessions; 2012 Mar 13; San Diego, CA. [view]
  59. Turakhia M. Methods to evaluate quality, effectiveness, and costs of treatment of atrial fibrillation. Presented at: Washington University School of Medicine Department of Epidemiology Grand Rounds; 2012 Feb 3; St. Louis, MO. [view]
  60. Turakhia M. New stroke prevention therapies: a clinical primer. Presented at: Stanford University School of Medicine Electrophysiology Conference; 2012 Jan 19; Stanford, CA. [view]
  61. Turakhia M. Newer Oral Anticoagulants and Percutaneous Left Atrial Appendage Closure to Prevent Strokes in Patients with Atrial Fibrillation. Presented at: American College of Cardiology Advances in Heart Disease Annual Meeting; 2011 Dec 16; San Francisco, CA. [view]
  62. Cheng Z, Zei PC, Hsia HH, Al-Ahmad A, Turakhia M, Daubert J, Zareba W, Moss AJ, Wang PJ. One Train of Antitachycardia Pacing is Successful For Fast Ventricular Tachycardia in Patients with Conduction Abnormalities and Left Ventricular Dysfunction: Results from the MADIT-CRT study. Poster session presented at: Heart Rhythm Society Annual Scientific Sessions; 2010 May 14; Denver, CO. [view]
  63. Shore S, Carey E, Turakhia M, Jackevicius CA, Cunningham F, Pilote L, Baron A, Grunwald G, Bradley SM, Maddox TM, Rumsfeld JS, Varosy PD, Ho M. Patterns of Adherence to Dabigatran and its Association with Outcomes. Paper presented at: American Heart Association Scientific Sessions and Resuscitation Annual Science Symposium; 2013 Nov 19; Dallas, TX. [view]
  64. Schneider PM, Liu W, Grunwald GK, Chan PS, Nallamothu BK, Sasson C, Varosy PD, Turakhia M, Ho PM, Bradley SM. Patterns of Waveform and Energy Use in Defibrillation for Cardiac Arrest: Insights from the Get With The Guidelines-Resuscitation Registry. Poster session presented at: American Heart Association Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke Annual Scientific Sessions; 2014 Jun 2; Baltimore, MD. [view]
  65. Hsu J, Maddox T, Kennedy K, Katz D, Marzec L, Gehi I, Turakhia M, Marcus GM. Predictors of Aspirin versus Oral Anticoagulant Prescription in Atrial Fibrillation Patients At-Risk for Stroke: Insights from the NCDR® PINNACLE Registry. Arrhythmias and Clinical EP: New Observations Affecting Clinical Management. Poster session presented at: American College of Cardiology Annual Scientific Session; 2014 Mar 30; Washington, DC. [view]
  66. Gupta A, Turakhia M, Heidenreich PA. Predictors of Defibrillator Implantation in an Eligible VA Population. Paper presented at: Heart Rhythm Society California Heart Rhythm Symposium; 2009 Sep 9; San Francisco, CA. [view]
  67. Flowers E, Molina C, Mathur A, Prasad M, Abrams L, Sathe A, Basra R, Malgesini N, Ratman G, Aouizerat BE, Turakhia M. Predictors of the Metabolic Syndrome in South Asians. Paper presented at: Bay Area Clinical Research Annual Symposium; 2009 Oct 28; San Francisco, CA. [view]
  68. Hsu JC, Maddox T, Kennedy K, Katz DF, Marzec L, Gehi A, Turakhia M, Marcus GM. Prescription of Oral Anticoagulation in Atrial Fibrillation Patients Across the Spectrum of Stroke Risk: Insights from the NCDR® PINNACLE Registry. Poster session presented at: Heart Rhythm Society Annual Scientific Sessions; 2014 May 8; San Francisco, CA. [view]
  69. Flowers E, Molina C, Mathur A, Prasad M, Abrams L, Sathe A, Malhotra D, Malgesini N, Ratman G, Aouizerat BE, Turakhia M. Prevalence of the Metabolic Syndrome in South Asians Residing in the United States. Paper presented at: University of California San Francisco Health Disparities Research Symposium; 2009 Oct 23; San Francisco, CA. [view]
  70. Prasad M, Flowers E, Molina C, Mathur A, Sathe A, Malhotra D, Basra R, Malgesini N, Ratman G, Aouizerat BE, Turakhia M. Prevalence of the Metabolic Syndrome in South Asians Residing in the United States. Paper presented at: Indian American Medical Association of California Meeting; 2009 Oct 31; Anaheim, CA. [view]
  71. Turakhia M, Shafrin J, Bognar K, Brown JB, Trocio J, Wiederkehr D, Goldman DP. Prevalence of undiagnosed non-valvular atrial fibrillation in the United States. Poster session presented at: American Heart Association Quality of Care and Outcomes Research Scientific Sessions; 2014 Jun 3; Baltimore, MD. [view]
  72. Turakhia M. Profile of Patients with Atrial Fibrillation in 2013: From the Highly Symptomatic Athlete to the Asymptomatic 85-Year-Old. Paper presented at: Transcatheter Cardiovascular Therapeutics Annual Scientific Conference; 2013 Oct 29; San Francisco, CA. [view]
  73. Turakhia M. Quality and Delivery of AF Care in India: Relevance of New AF Guidelines. Keynote Lecture. Presented at: Indian College of Cardiology Annual Conference; 2014 Sep 20; Tirupati, India. [view]
  74. Rajaei S, Groeneveld P, Teerlink J, Whooley M, Turakhia M, Richman IB, Sahay A, Kini V, Heidenreich PA. Racial disparities in echocardiography use within the Veterans Administration and Medicare systems. Poster session presented at: Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke Annual Scientific Forum; 2015 Apr 29; Baltimore, MD. [view]
  75. Yong C, Xu X, Than CT, Ullal A, Schmitt S, Azarbal F, Heidenreich PA, Tsoi A, Turakhia M. Racial Disparities in Warfarin Time in INR Therapeutic Range in Patients with Atrial Fibrillation: Findings from the TREAT-AF Study. Paper presented at: American Heart Association Scientific Sessions and Resuscitation Annual Symposium; 2013 Nov 19; Dallas, TX. [view]
  76. Turakhia M, Cao M, Arnold E, Dalal N, Fayram T, Gold MP. Reduced Mortality With Quadripolar Compared to Bipolar Left Ventricular Leads in Cardiac Resynchronization Therapy. Paper presented at: CARDIOSTIM World Congress in Cardiac Electrophysiology and Cardiac Techniques; 2014 Jun 18; Nice, France. [view]
  77. Turakhia M, Cao M, Arnold E, Dalal N, Fayram T, Gold MP. Reduced Mortality with Quadripolar Versus Bipolar Left Ventricular Leads in Cardiac Resynchronization Therapy. Poster session presented at: Heart Rhythm Society Annual Scientific Sessions; 2014 May 7; San Francisco, CA. [view]
  78. Turakhia M. Reducing Stroke Risk in Atrial Fibrillation, Moderator. Presented at: American College of Cardiology Annual Scientific Session; 2014 Mar 30; Washington, DC. [view]
  79. Ladapo J, Turakhia M, Landry-Wilson EM, Ryan MP, Irish W, Mollenkopf SA, Reynolds MR. Remote Monitoring of Implantable Cardiovascular Devices is Associated with Reductions in Healthcare Utilization. Poster session presented at: Heart Rhythm Society Annual Scientific Sessions; 2014 May 8; San Francisco, CA. [view]
  80. Turakhia M, Fan J, Schmitt S, Lee J, Than CT, Ullal A, Perez M, Wang PJ, Heidenreich PA. Safety and effectiveness of catheter ablation of atrial fibrillation in chronic kidney disease: Data from 25,850 patients. Poster session presented at: Heart Rhythm Society Annual Scientific Sessions; 2014 May 10; San Francisco, CA. [view]
  81. Turakhia M, Phibbs CS, Schmitt S, Moos RH, Heidenreich PA, Le S, Frayne SM. Systematic Variation of Facility Quality of Anticoagulation for Atrial Fibrillation: A National VA Study. Paper presented at: VA HSR&D Career Development Annual Meeting; 2010 Feb 25; San Francisco, CA. [view]
  82. Turakhia M. The changing landscape of atrial fibrillation: Methods of assessing effectiveness, quality, and costs. Presented at: University of Pittsburgh School of Medicine Visiting Professor Lecture; 2010 Oct 4; Pittsburgh, PA. [view]
  83. Ullal AJ, Hoang DD, Perez M, Freeman JV, Than CT, Heidenreich PA, Turakhia M. The Early Repolarization Pattern in Athletes: A Systematic Review and Meta-Analysis. Poster session presented at: Heart Rhythm Society Annual Scientific Sessions; 2014 May 10; San Francisco, CA. [view]
  84. Turakhia M. The Mega-Cohort: Linking Large Datasets for Comparative Effectiveness Research for Heart Rhythm Disorders. Presented at: Stanford University Cardiovascular Institute Seminar; 2012 Feb 28; Stanford, CA. [view]
  85. Chiu VY, Turakhia M, Phibbs CS, Moos RH, Schmitt SK, Le SY, Friedman SA, Frayne SM. Time to Next INR as an Anticoagulation Quality Measure in Atrial Fibrillation. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2010 Apr 28; Minneapolis, MN. [view]
  86. Goldstein BA, Turakhia M, Arce CM, Winkelmayer WC. Trends in the Incidence of Atrial Fibrillation in Older Patients Initiating Dialysis in the United States. Poster session presented at: European Renal Association-European Dialysys and Transplant Association Annual Congress; 2012 May 24; Paris, France. [view]
  87. Khazanie P, Greiner M, Al-Khatib S, Piccini JP, Turakhia M, Varosy P, Masoudi F, Curtis L, Hernandez A. Use and Comparative Effectiveness of Cardiac Resynchronization Therapy among Patients with Heart Failure and Atrial Fibrillation: Data from the NCDR® Registry. Device Therapies in Heart Failure and Cardiomyopathies. Poster session presented at: American College of Cardiology Annual Scientific Session; 2014 Mar 29; Washington, DC. [view]
  88. Rajaei S, Groeneveld P, Teerlink J, Whooley M, Turakhia M, Richman IB, Sahay A, Kini V, Heidenreich PA. Use of echocardiography and nuclear scintigraphy for patients with heart failure in the Veterans Administration and Medicare systems. Poster session presented at: Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke Annual Scientific Forum; 2015 Apr 29; Baltimore, MD. [view]
  89. Turakhia M. Using large-scale observational data to answer clinical questions for treatment of atrial fibrillation. Presented at: Stanford University Cardiovascular Institute Seminar; 2012 Mar 1; Stanford, CA. [view]
  90. Yang F, Xu X, Hoang DD, Heidenreich PA, Turakhia M. Warfarin use in veterans with incident atrial fibrillation and severe renal dysfunction. Poster session presented at: Bay Area Clinical Research Annual Symposium; 2011 Nov 4; San Francisco, CA. [view]
  91. Turakhia M. When Nice Becomes Necessary: Quartet LV Lead Improving Outcomes and Reducing Costs. Presented at: CARDIOSTIM World Congress in Cardiac Electrophysiology and Cardiac Techniques; 2014 Jun 18; Nice, France. [view]
  92. Turakhia M. When, Why, and How to Cardiovert. Poster session presented at: Transcatheter Cardiovascular Therapeutics Annual Scientific Conference; 2013 Oct 29; San Francisco, CA. [view]


DRA: Cardiovascular Disease
DRE: Epidemiology, Prevention
Keywords: Cardiovasc’r disease, Care Management
MeSH Terms: none

Questions about the HSR website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.